Grandiose talk of worldwide relief and justice has been accompanied by little to no action. Now the group’s options are narrowing. Vidya Krishnan 6:00 AM ET Rohingya refugees take part in a prayer at the Kutupalong camp in Cox’s Bazar, Bangladesh.Rafiqur Rahman / Reuters COX’S BAZAR, Bangladesh—Mohib Ullah does not come across as an international advocate, the face of a community at risk. The 44-year-old botanist is mild-mannered, giving off the air of a kindly schoolteacher.
Hundreds of thousands of Rohingya refugees who fled mass slaughter in Myanmar listened somberly as former teacher Mohib Ullah spoke about their homeland while at a camp in southern Bangladesh. Ullah, who has emerged as a Rohingya leader trying to galvanize international, political and financial support for the refugees, had stepped onstage at the world’s largest settlement of refugees.
On 24 March 2016, on the occasion of World Tuberculosis Day, JP Nadda, India’s health minister at the time, announced the launch of bedaquiline in India. Bedaquiline is a new anti-tuberculosis drug that works on patients with drug-resistant TB, or DR-TB. The government announced that it would be giving the drug for free, under a national programme to eliminate TB. India is home to the most number of TB patients in the world.